Octapharma AG - octaplas / octaplasLG - Tolerability and Safety in Plasma Transfusion 
EN: Navigation mit Access Keys
- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Kontakt
- [Alt + 4] - Sitemap
- [Alt + 5] - Suche
Tolerability and safety in plasma transfusion
EN: Hauptnavigation
Tolerability and safety in plasma transfusion
octaplasLG product information
 |
| OctaplasLG SPC |
octaplas product information
 |
| Octaplas Product Characterisation |
 |
| Octaplasma PM Canada- English |
 |
| Octaplasma PM Canada- French |
octaplas / octaplasLG - Tolerability and Safety in Plasma Transfusion
pharmaceutically licensed, SD-treated, prion reduced human plasma for transfusion. With more than 6 million units used, octaplas® has demonstrated to avoid transfusion related acute lung injury (TRALI) and reduce adverse reactions, setting new standards in transfusion medicine.
Available in 200 ml bags in A, B, O and AB blood groups.
- Standardised coagulation factors content
- Enhanced prion safety & virally inactivated
- No risk of TRALI
- Solvent-detergent (S/D) treatment optimised
